ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
9,896,154
Share change
+1,519,687
Total reported value
$82,459,538
Put/Call ratio
261%
Price per share
$8.32
Number of holders
63
Value change
+$20,558,773
Number of buys
44
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q1 2021

As of 31 Mar 2021, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,896,154 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Invesco Ltd., Parkman Healthcare Partners LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Ikarian Capital, LLC, AMERIPRISE FINANCIAL INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and BRIGHTON JONES LLC. This page lists 63 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.